Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
about
Lipid abnormalities in kidney disease and management strategiesResidual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density LipoproteinStatins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis RiskAssociation of relatives of hemodialysis patients with metabolic syndrome, albuminuria and Framingham Risk Score.Increased risk of ventricular tachycardia and cardiovascular death in patients with myocarditis during the long-term follow-up: A national representative cohort from the National Health Insurance Research Database.Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama StudyGlomerular tip adhesions predict the progression of IgA nephropathyAssociation of dyslipidemia with renal outcomes in chronic kidney disease.Risks of rapid decline renal function in patients with type 2 diabetesMetabolic syndrome and renal injuryLipid levels and renal function decline in pre-dialysis patients.Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital.Cholesterol Metabolism in CKDCKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis.Risk factors of gender for renal progression in patients with early chronic kidney disease.Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort.Peripheral arterial stiffness is independently associated with a rapid decline in estimated glomerular filtration rate in patients with type 2 diabetesStatin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation.Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients.
P2860
Q27024982-A7F05EAF-B33F-4EB2-BFC8-B21489A597A5Q28083619-EA6ED269-7C45-472A-9744-884B67E3CBE3Q28554193-111E1DDD-1EFD-4307-A15E-1215883E0AACQ33577804-035C7248-D9D6-40E8-8F3F-B6CD7A766461Q33644095-2ACB935B-D7A0-4B18-83C2-9DD6BC5855EFQ33835707-265D14E9-B9A8-4F0C-99E5-067FE423F3B6Q33918753-951A91F6-DDC2-4B3E-84F2-A1ABF49AAF2DQ34524136-EEDC726C-9F6A-45C8-B002-EBD8975F6033Q34580123-8EDDF55A-3F1E-4532-ADF1-B135D6CF7FAEQ34699197-5A54BEE7-1E5E-49D4-B4D5-10BF7CDDCE0EQ34725449-FE74F86C-AA8A-4FF2-BF50-BCA5277ABE67Q35204390-A449904E-7FDC-4FEE-BA62-30C0F9EFD620Q36129870-CE9F54AE-2758-4CF2-B2D1-459D70F89464Q36228385-6CE5638A-0C9C-421B-B46C-CBD64F4C5F7CQ36315574-E4A319B1-2E38-4F5E-8B92-8247F8774BAAQ36371060-24AA3EB4-B3CF-4699-AF7C-E525BA0AD46AQ37605595-CCF97A8F-A317-4FB7-9274-D5AA81A26F23Q40224049-3D1B733A-14A1-4E4D-98A6-1CF23CDB3EEBQ41771923-D75467AA-1DBC-4F9A-A465-94A59C7F1818Q47106229-3021A71C-C708-4DAD-B4FF-6FD3F450B832Q49959013-A5DA3E6A-D124-4B7D-95F4-1113EE1F96C3
P2860
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@ast
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@en
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@nl
type
label
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@ast
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@en
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@nl
prefLabel
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@ast
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@en
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@nl
P2093
P2860
P356
P1476
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease
@en
P2093
Allan J Collins
Gerald J Beck
John W Kusek
Mark J Sarnak
Tom Greene
Vandana Menon
Varun Chawla
P2860
P304
P356
10.2215/CJN.01450210
P577
2010-06-17T00:00:00Z